Erratum: Should society allow research ethics boards to be run as for-profit enterprises? (PLoS Medicine 3:7 DOI 10.1371/journal.pmed.0030309);Should society allow research ethics boards to be run as for-profit enterprises?

PLoS Medicine

Volumn 3, Issue 7, 2006, Pages 0941-0944

  Emanuel, Ezekiel J ^a   Lemmens, Trudo ^b   Elliot, Carl ^c  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTECHNOLOGY; DRUG INDUSTRY; ETHICS; HEALTH CARE ORGANIZATION; HEALTH CARE PLANNING; HEALTH CARE QUALITY; HEALTH CENTER; HEALTH PROGRAM; HUMAN; MEDICAL INFORMATICS; MEDICAL PROFESSION; MEDICAL RESEARCH; PROFESSIONAL STANDARD; PROFIT; REVIEW; UNIVERSITY HOSPITAL; ARTICLE; ECONOMICS; HUMAN EXPERIMENT; ORGANIZATION AND MANAGEMENT; RESEARCH ETHICS;

BIOMEDICAL RESEARCH; ETHICAL REVIEW; ETHICS COMMITTEES, RESEARCH; ETHICS, RESEARCH; HUMAN EXPERIMENTATION; HUMANS;

EID: 33746400585     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.0030391     Document Type: Erratum

References (19)

1. Steinbrook M (2005) Gag clauses in clinical-trial agreements. N Engl J Med 352: 2160-2162.
2. Krimsky S (2003) Science in the private interest: Has the lure of profits corrupted biomedical research?. Lanham (Maryland): Rowman and Littlefield. 247 p.
3. Bekelman J, Li Y, Gross CP (2003) Scope and impact of financial conflicts of interest in biomedical research: A systematic review. JAMA 289: 454-465.
4. Bodenheimer T (2000) Uneasy alliance - Clinical investigators and the pharmaceutical industry. N Engl J Med 342: 1539-1544.
5. Lemmens T (2004) Leopards in the temple: Restoring scientific integrity to the commercialized research scene. J Law Med Ethics 32: 641-657.
6. Lemmens T, Freedman B (2000) Ethics review for sale? Conflict of interest and commercial research review boards. Milbank Q 78: 547-584.
7. Evans D, Smith M, Willen L (2005) Big pharma's shameful secret. Bloomberg Mark 14: 36-62.
8. Francis L (1996) IRBs and conflicts of interest. In: Spece RG, Shimm DS, Buchanan AE, editors. Conflicts of interest in clinical practice and research. New York: Oxford University Press. pp. 418-436.
9. Federman DD, Hanna KE, Lyman Rodriguez L, editors (2003) Responsible research: A systems approach to protecting research participants. Washington (D. C.): National Academies Press. 290 p.
10. Department of Health and Human Services Office of Inspector General (1998) Institutional review boards: The emergence of independent boards. Washington (D. C.): Department of Health and Human Services Office of Inspector General. Available: http://oig.hhs.gov/oei/reports/oei-01-97-00192.pdf. Accessed 31 May 2006.
11. Elliott C, Lemmens T (2005 December 15) Ethics for sale: For-profit ethical review coming to a clinical trial near you. Slate. Available: http://www.slate.com/id/2132187. Accessed 31 May 2006.
12. Evans D (2005) Garry Polsgrove's last battle. Bloomberg Markets 14: 42-43.
13. Evans D (2005 December 15) SFBC drug testers have tuberculosis after exposure at centre. Bloomberg News. Available: http://www.bloomberg.com/apps/ news?pid=10000039&sid=a90OZzPRlkaE&refer=columnist_evans. Accessed 31 May 2006.
14. Groupe de Travail "Réglementation des Essais Cliniques" (2000) Rapport final à l'intention de l'Office Intercantonal de Contrôle des Médicaments. Berne: Office Intercantonal de Contrôle des Médicaments.
15. Swiss Bundesgerichts Second Public Law Division (2003 July 4) Freiburger Ethik-Kommission International v. Regierungsrat des Kantons Basel-Landschaft (2A.450/2002).
16. Jost A (2003) Arrêt du 4 juillet de la IIème cour de droit public du Tribunal Fédéral, Freiburger Ethik-Kommission International c. Bâle-Campagne. Rev Suisse Droit Santé 1: 1.
17. Emanuel EJ, Wood A, Fleischman A, Bowen A, Getz KA, et al. (2004) Oversight of human participants research: Identifying problems to evaluate reform proposals. Ann Intern Med 141: 282-291.
18. Wood A, Grady C, Emanuel EJ (2004) Regional ethics organizations for protection of human research participants. Nat Med 10: 1283-1288.
19. Boyd EA, Cho MK, Bero LA (2003) Financial conflict-of-interest policies in clinical research: Issues for clinical investigators. Acad Med 78: 769-774.